Developing World / LMICs


While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions.  Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Developing World, specifically low and low-middle income countries (LMICs, as defined by the World Bank) through the speed and cost-effectiveness of medical repurposing.

Our events and research within the the Developing World Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.


Read our news release from April 21, 2022 here, describing the 10 DEI clinical trials recently selected, including 3 in LMICs!

Our ongoing LMIC trials:

Open Funding Opportunity for the Developing World / LMICs:

ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): budgets of up to US$60,000 for clinical repurposing trials in any disease led by underserved researchers in any LMIC (as defined by the World Bank). CLOSED; SUBMISSIONS UNDER REVIEW.

More information on our Funding Opportunities / RFPs page.

Three Trials from our 2022 RFP, ongoing now:


Three Trials Funded in 2021, ongoing now:


Three Trials Based in LMICs Funded in 2020, 2 ongoing now, 1 completed:

Dr. Hamaluba researching snakebites in Kenya

Dr. Nguyen researching a rare pediatric liver disease biliary atresia in Vietnam

COMPLETED: Dr. Adewole researching tuberculosis in Nigeria



Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.

Real World Data Through a Patient’s Lens
October 2021
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.

Repurposing for Pediatric Patients: Best Practices and Lessons Learned
November 2020
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.

How Patients Impact the 505(b)(2) Regulatory Process
October 2020
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.

CureAccelerator Live! for the Developing World 2019
May 2019
Boston, MA
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.